Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Molecular Templates Inc (MTEM)
NASDAQ:MTEM
Molecular Templates (MTEM) Stock Price & Analysis
507 Followers
MTEM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.68 - $9.46
Previous Close$1.78
Volume87.91K
Average Volume (3M)61.30K
Market Cap
$9.57M
Enterprise Value$7.81M
Total Cash (Recent Filing)$11.50M
Total Debt (Recent Filing)$9.74M
Price to Earnings (P/E)-1.1
Beta1.29
Next Earnings
May 13, 2024EPS Estimate
-$0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.56
Shares Outstanding5,374,268
10 Day Avg. Volume246,925
30 Day Avg. Volume61,298
Standard Deviation0.22
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)2.41
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.12
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Molecular Templates News
PremiumCompany Announcements
Molecular Templates Inc Announces Layoffs, CMO Resignation
PremiumPress Releases
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism
PremiumCompany Announcements
Molecular Templates Inc Raises Funds for Clinical StudiesRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MTEM FAQ
What was Molecular Templates Inc’s price range in the past 12 months?
Molecular Templates Inc lowest stock price was $1.68 and its highest was $9.46 in the past 12 months.
What is Molecular Templates Inc’s market cap?
Currently, no data Available
When is Molecular Templates Inc’s upcoming earnings report date?
Molecular Templates Inc’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were Molecular Templates Inc’s earnings last quarter?
Molecular Templates Inc released its earnings results on Mar 29, 2024. The company reported -$0.73 earnings per share for the quarter, beating the consensus estimate of -$0.97 by $0.24.
Is Molecular Templates Inc overvalued?
According to Wall Street analysts Molecular Templates Inc’s price is currently Overvalued.
Does Molecular Templates Inc pay dividends?
Molecular Templates Inc does not currently pay dividends.
What is Molecular Templates Inc’s EPS estimate?
Molecular Templates Inc’s EPS estimate is -$0.78.
How many shares outstanding does Molecular Templates Inc have?
Molecular Templates Inc has 5,374,268 shares outstanding.
What happened to Molecular Templates Inc’s price movement after its last earnings report?
Molecular Templates Inc reported an EPS of -$0.73 in its last earnings report, beating expectations of -$0.97. Following the earnings report the stock price went down -2.5%.
Which hedge fund is a major shareholder of Molecular Templates Inc?
Among the largest hedge funds holding Molecular Templates Inc’s share is Woodline Partners LP. It holds Molecular Templates Inc’s shares valued at N/A.
---
Molecular Templates Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 496.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $587.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.75%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-63.73%
Trailing 12-Months
Company Description
Molecular Templates Inc
Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded on October 17, 2001 and is headquartered in Austin, TX.
---
Technical Analysis
---